Rare diseases
Investigational molecules
Locations
Back to France1 745 clinical trials in Roubaix, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on BI 1015550 for Improving Lung Function in Patients with Progressive Fibrosing Interstitial Lung Diseases
FranceStudy on the Effects of Isatuximab with Bortezomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
FranceStudy on Long-Acting Cabotegravir and Lenacapavir for HIV Patients: Evaluating Dual Antiretroviral Therapy
FranceStudy on Stopping or Continuing Anastrozole, Letrozole, and Exemestane for Patients with Advanced or Metastatic Low-Grade Endometrial Stromal Sarcoma
FranceStudy on [68Ga]Ga-PentixaFor for Staging and Evaluation in Symptomatic Multiple Myeloma Patients in Initial Treatment or Relapse
FranceStudy of Efgartigimod PH20 SC for Adults with Thyroid Eye Disease
FranceStudy of OMX-0407 for Patients with Previously Treated Unresectable Solid Tumors
FranceStudy on the Effects of Sparsentan and Irbesartan for Patients with Primary Focal Segmental Glomerulosclerosis (FSGS)
FranceStudy on the Effects of Camlipixant in Adults with Refractory or Unexplained Chronic Cough
FranceLong-term Study of Sotatercept for Adults with Pulmonary Arterial Hypertension (PAH)
FranceStudy on the Effectiveness and Safety of Golcadomide and Rituximab for Patients with Newly Diagnosed Advanced Follicular Lymphoma
FranceStudy of Nivolumab for Children and Adults with Relapsed or Refractory ALK+ Anaplastic Large Cell Lymphoma
FranceThe busiest research cities in the country
What the registry says about research in the country
Research focusing on innovative treatments for Multiple Myeloma and various forms of leukemia, including comparative studies of novel therapeutic combinations and traditional approaches.
Studies evaluating treatment effectiveness in newly diagnosed patients and those with advanced disease stages.
Innovative research exploring potential treatments for Alzheimer's disease, including studies on caffeine's effects on cognitive function in early-to-moderate stage patients.
Focus on non-pharmacological interventions and their impact on disease progression.
Clinical investigations into severe asthma management and pulmonary infections, including studies on treatment optimization and novel therapeutic approaches.
Evaluation of long-term treatment strategies and comparative medication studies.
Research examining hypertension management in patients with chronic kidney disease, along with studies on thrombo-embolic complications prevention.
Focus on optimizing treatment strategies for complex cardiovascular conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
